Search results for " cD"

showing 10 items of 587 documents

Genome-wide association meta-analysis for early age-related macular degeneration highlights novel loci and insights for advanced disease

2020

Abstract Background Advanced age-related macular degeneration (AMD) is a leading cause of blindness. While around half of the genetic contribution to advanced AMD has been uncovered, little is known about the genetic architecture of early AMD. Methods To identify genetic factors for early AMD, we conducted a genome-wide association study (GWAS) meta-analysis (14,034 cases, 91,214 controls, 11 sources of data including the International AMD Genomics Consortium, IAMDGC, and UK Biobank, UKBB). We ascertained early AMD via color fundus photographs by manual grading for 10 sources and via an automated machine learning approach for > 170,000 photographs from UKBB. We searched for early AMD loc…

0301 basic medicinegenetic structures610 MedizinGenome-wide association studyMacular Degeneration0302 clinical medicineAdvanced diseaseCD46Genetics (clinical)GeneticsInternational AMD genomics consortium (IAMDGC)ddc:6100303 health sciencesGenome-wide association study (GWAS)3. Good health030220 oncology & carcinogenesisAge-related macular degeneration (AMD)Meta-analysisResearch ArticleGenetic Markerslcsh:Internal medicineUK biobank (UKBB)lcsh:QH426-470Locus (genetics)GenomicsComputational biologyBiologyPolymorphism Single NucleotideGenome-wide association study (GWAS) Meta-analysis Age-related macular degeneration (AMD) Early AMD CD46 TYR International AMD genomics consortium (IAMDGC) UK biobank (UKBB) Machine-learning Automated phenotyping03 medical and health sciencesEarly AMDGeneticsmedicineHumansGenetic Predisposition to DiseaseGenome-wide Association Study (gwas) ; Meta-analysis ; Age-related Macular Degeneration (amd) ; Early Amd ; Cd46 ; Tyr ; International Amd Genomics Consortium (iamdgc) ; Uk Biobank (ukbb) ; Machine-learning ; Automated Phenotypinglcsh:RC31-1245Machine-learning030304 developmental biologyTYRCD46Macular degenerationmedicine.diseaseHuman geneticseye diseasesGenetic architectureMeta-analysislcsh:Genetics030104 developmental biologyGenetic LociCase-Control StudiesAutomated phenotypingHTRA1030221 ophthalmology & optometrysense organsGenome-Wide Association Study
researchProduct

The janus face of NKT cell function in autoimmunity and infectious diseases

2018

Natural killer T cells (NKT) are a subset of T lymphocytes bridging innate and adaptive immunity. These cells recognize self and microbial glycolipids bound to non-polymorphic and highly conserved CD1d molecules. Three NKT cell subsets, type I, II and NKT-like expressing different antigen receptors (TCR) were described and TCR activation promotes intracellular events leading to specific functional activities. NKT can exhibit different functions depending on the secretion of soluble molecules and the interaction with other cell types. NKT cells act as regulatory cells in the defence against infections but, on the other hand, their effector functions can be involved in the pathogenesis of sev…

0301 basic medicineglycolipidsAutoimmunityReviewAdaptive Immunitymedicine.disease_causeAutoimmunityCatalysiimmunologylcsh:Chemistry0302 clinical medicineT-Lymphocyte Subsetslcsh:QH301-705.5SpectroscopyInnate lymphoid cellhemic and immune systemsComputer Science Applications1707 Computer Vision and Pattern RecognitionGeneral MedicineNKTNatural killer T cellAcquired immune systemComputer Science ApplicationsCell biologyCD1DmicrobesCell typechemical and pharmacologic phenomenaGlycolipidBiologyCD1dCommunicable DiseasesCatalysisInorganic Chemistry03 medical and health sciencesmedicineAnimalsHumansMicrobePhysical and Theoretical ChemistryMolecular BiologyInflammationT-cell receptorOrganic ChemistryModels ImmunologicalAlpha-galactosylceramideAlpha-galactosylceramide; Autoimmunity; CD1d; Glycolipids; Microbes; NKT; Sulfatide; Catalysis; Molecular Biology; Spectroscopy; Computer Science Applications1707 Computer Vision and Pattern Recognition; Physical and Theoretical Chemistry; Organic Chemistry; Inorganic ChemistryImmunity InnateSettore MED/16 - Reumatologia030104 developmental biologylcsh:Biology (General)lcsh:QD1-999biology.proteinNatural Killer T-CellsSulfatideCD8030215 immunology
researchProduct

Inactivation of the KSRP gene modifies collagen antibody induced arthritis.

2017

Abstract The KH type splicing regulatory protein (KSRP) is a nucleic acid binding protein, which negatively regulates the stability and/or translatability of many mRNA species encoding immune-relevant proteins. As KSRP is expressed in immune cells including T and B cells, neutrophils, macrophages and dendritic cells, we wanted to analyze its importance for the development of autoimmune diseases. We chose collagen antibody-induced arthritis (CAIA) as an appropriate autoimmune disease mouse model in which neutrophils and macrophages constitute the main effector cell populations. We compared arthritis induction in wild type (WT) and KSRP−/− mice and paws were taken for histological sections an…

0301 basic medicinemedicine.drug_classmedicine.medical_treatmentInflammatory arthritisChemokine CXCL1ImmunologyArthritisAntigens Differentiation MyelomonocyticNitric Oxide Synthase Type IISpleenBiologyMonoclonal antibodyPeripheral blood mononuclear cellAntibodiesFlow cytometry03 medical and health sciencesInterferon-gammaMiceImmune systemAntigens CDmedicineAnimalsAntigens LyCalgranulin ARNA MessengerMolecular BiologyInflammationmedicine.diagnostic_testTumor Necrosis Factor-alphaMacrophagesRNA-Binding Proteinsmedicine.diseaseMolecular biologyArthritis ExperimentalLymphocyte Function-Associated Antigen-1Mice Inbred C57BL030104 developmental biologyCytokinemedicine.anatomical_structureImmunologyTrans-ActivatorsCytokinesCollagenMolecular immunology
researchProduct

Behavioral and clinical characteristics of people receiving medical care for HIV infection in an outpatient facility in Sicily, Italy

2016

Paola Di Carlo,1 Giuliana Guadagnino,1 Palmira Immordino,1 Giovanni Mazzola,2 Pietro Colletti,2 Ilenia Alongi,1 Lucia Adamoli,1 Francesco Vitale,1 Alessandra Casuccio1 1Department of Sciences for Health Promotion and Mother-Child Care “G D’Alessandro”, University of Palermo, 2Department of Medicinal Clinics and Emerging Diseases, “Paolo Giaccone” Polyclinic University Hospital, Palermo, Italy Aim: The authors examined a cohort of HIV-positive outpatients at the AIDS Center of Palermo University in Italy in order to identify factors related to the frequency of their visits to the outpatient facility for health care services.Methods: Two hundr…

0301 basic medicinemedicine.medical_specialtyMultivariate analysisSettore MED/17 - Malattie Infettivehard-to-reach groups030106 microbiologyHuman immunodeficiency virus (HIV)Medicine (miscellaneous)HIV Outpatient Servicemedicine.disease_causeSettore MED/42 - Igiene Generale E Applicata03 medical and health sciences0302 clinical medicineOutpatient facilityAmbulatory careAcquired immunodeficiency syndrome (AIDS)CD4+ T-cell countHealth careMedicine030212 general & internal medicinePharmacology Toxicology and Pharmaceutics (miscellaneous)Access to care; CD4+ T-cell count; Hard-to-reach groups; HIV infection; HIV outpatient service; Resource use; Social Sciences (miscellaneous); Medicine (miscellaneous); Health Policy; Pharmacology Toxicology and Pharmaceutics (miscellaneous)Original Researchaccess to carelcsh:R5-920business.industryHealth PolicyUnivariatemedicine.diseaseHIV infectionresource usePatient Preference and AdherenceEmergency medicineCohortbusinesslcsh:Medicine (General)Hard-to-reach groupSocial Sciences (miscellaneous)
researchProduct

Pirmā tipa cukura diabēts un tā sarežģījumi grūtniecības laikā

2018

Grūtniecība 1.tipa CD pacientēm var noritēt veiksmīgi, ja glikozes līmenis asinīs ir tuvu normas robežai gan plānojot grūtniecību, gan tās laikā. Tādēļ ir svarīgi izprast glikozes metabolisma izmaiņas grūtniecības laikā un to ietekmi uz augļa un mātes veselību, samazinot komplikāciju risku grūtniecības laikā. Pētījuma mērķis bija analizēt ar 1.tipa CD saistītos sarežģījumus grūtniecēm un viņu jaundzimušajiem. Pētījuma uzdevumi bija izpētīt CD apmācības un HbA1c līmeņa saistību ar grūtniecības iznākumu, kā arī izpētīt iespējamos ar metabolo kompensāciju saistītos sarežģījumus katrā grūtniecības trimestrī un pēcdzemdību periodā un noskaidrot grūtnieces svara ietekmi uz grūtniecības iznākumu. …

1. tipa CDPirmā tipa cukura diabētsinsulīnsMedicīnagrūtniecībaCD
researchProduct

Measurement of the W boson mass

1996

The W boson mass is measured using proton-proton collision data at root s = 13 TeV corresponding to an integrated luminosity of 1.7fb(-1) recorded during 2016 by the LHCb experiment. With a simultaneous fit of the muon q/p(T) distribution of a sample of W ->mu y decays and the phi* distribution of a sample of Z -> mu mu decays the W boson mass is determined to be

13000 GeV-cmsTevatronparton: distribution functionQC770-798W: leptonic decay7. Clean energy01 natural sciencesLuminosityPhysics Particles & FieldsSubatomär fysikHadron-Hadron scattering (experiments)scattering [p p]Electroweak interactionNuclear Experimentparticle identification [muon]Settore FIS/01PhilosophyPhysicsCoupling (probability)CERN LHC CollHadron colliderPhysical SciencesTransverse masscolliding beams [p p]distribution function [parton]Collider Detector at FermilabParticles and fieldCOLLISIONSp p: scatteringCERN PBARP COLLIDERAstrophysics::High Energy Astrophysical PhenomenaW: mass: measuredStandard ModelNuclear physicsddc:530010306 general physics0206 Quantum PhysicsMuonScience & Technology010308 nuclear & particles physicsWeinberg angleHEPFERMILAB TEVATRONElectroweak interaction Hadron-Hadron scattering (experiments) QCD For- ward physicsCDFp p: colliding beamsPhysics::Instrumentation and DetectorsElectron–positron annihilation= 1.8 TEVGeneral Physics and Astronomy= 1.8 TEV; PBARP COLLISIONS; DECAYVector bosonHigh Energy Physics - ExperimentHigh Energy Physics - Experiment (hep-ex)Computer Science::Systems and ControlSubatomic Physics[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]PhysicFermilabBosonPhysics0105 Mathematical PhysicsStatistics::ApplicationsSettore FIS/01 - Fisica Sperimentalestatistical [error]Nuclear & Particles PhysicsCENTRAL TRACKING CHAMBERerror: statisticalCENTRAL ELECTROMAGNETIC CALORIMETERTransverse momentum0202 Atomic Molecular Nuclear Particle and Plasma PhysicsLHCmass: measured [W]Particle Physics - ExperimentStatistics::TheoryParticle physicsNuclear and High Energy Physicselectroweak interaction: precision measurementRegular Article - Experimental PhysicsTRANSVERSE ENERGYFOS: Physical sciencesmuon: particle identification530Particle decayPBARP COLLISIONSNuclear and particle physics. Atomic energy. Radioactivityprecision measurement [electroweak interaction]0103 physical sciencesForward physicVECTOR BOSONElectroweak interaction Hadron-Hadron scattering (experiments) QCD Forward physicsCERN PBARP COLLIDER; CENTRAL ELECTROMAGNETIC CALORIMETER; CENTRAL TRACKING CHAMBER; = 1.8 TEV; PARTON DISTRIBUTIONS; FERMILAB TEVATRON; VECTOR BOSON; TRANSVERSE ENERGY; CDF; COLLISIONShep-exHigh Energy Physics::PhenomenologyLHC-BQCDleptonic decay [W]LHCbPARTON DISTRIBUTIONSMass spectrumForward physicsPhysics::Accelerator PhysicsHigh Energy Physics::ExperimentDECAYHumanitiesexperimental results
researchProduct

2. tipa cukura diabēta pacientu individualizēta terapija un tās nozīmēšanas kritēriji atbilstoši fenotipam

2015

2.tipa cukura diabēts ir hroniska slimība,kuras izplatība strauji pieaug visā pasaulē.Neraugoties uz izstrādātām vadlīnijām ārstiem,kā sākt2.tipaCD ārstēšanu,ne visi pacienti sasniedz mērķa glikēmiju un glikēta hemoglobīna(HbA1c)līmeni.Izpētīti228akūti hospitalizēti 2.tipaCD pacienti,kuri ārstējās no2013.gada janvāra līdz2014.gada septembrim.Liela uzmanība pievērsta pacientu bioķīmiskajiem radītājiem:triglicerīdi(TG), c-peptīds,HbA1c,GFĀ,ĶMI,ārstam,kas ārstēja noteiktu pacientu,terapijas izvēlei,pacientam izrakstoties no stacionāra. Fenotipiski pacienti sadalīti četrās grupās.Pirmajā grupā bija73pacienti ar hronisku nieru slimību(GFĀ30 kg/m2),66cilvēki bija vecāka gadagājuma pacientu grupā(…

2. tipa CD ārstēšanas rekomendācijas2. tipa cukura diabētsIndividualizēta 2. tipa CD ārstēšana2. tipa CD fenotipiMedicīna2. tipa CD terapija
researchProduct

Inhibición de complejos cdk/ciclina en modelos celulares de patología

2012

La proliferación celular descontrolada es el resultado de diversos mecanismos que conducen a un proceso patológico. Uno de ellos, es el desarrollo de aberraciones en cualquier punto de la maquinaria molecular que gobierna el ciclo celular y otro es la desregulación del receptor del factor de crecimiento epidérmico (EGFR). Los tratamientos tumorales convencionales han mejorado sin duda durante las últimas décadas, pero sigue siendo necesaria la búsqueda de nuevas estrategias terapéuticas. Las nuevas terapias están dirigiéndose hacia la inhibición simultanea de rutas proximales, puede favorecer la efectividad de los tratamientos antitumorales. En este trabajo de tesis presentamos los estudios…

:CIENCIAS MÉDICAS::Farmacodinámica::Acción de los medicamentos [UNESCO]:CIENCIAS DE LA VIDA::Biología celular [UNESCO]:CIENCIAS DE LA VIDA::Bioquímica [UNESCO]UNESCO::CIENCIAS MÉDICAS::Farmacodinámica::Acción de los medicamentos:CIENCIAS MÉDICAS::Farmacología::Medicamentos sintéticos [UNESCO]UNESCO::CIENCIAS DE LA VIDA::Bioquímicainhibidores cdk/ciclina antitumoralesUNESCO::CIENCIAS DE LA VIDA::Biología celularUNESCO::CIENCIAS MÉDICAS::Farmacología::Medicamentos sintéticos
researchProduct

Synthetic Polyclonal-Derived CDR Peptides as an Innovative Strategy in Glaucoma Therapy

2019

The pathogenesis of glaucoma is strongly associated with the occurrence of autoimmune-mediated loss of retinal ganglion cells (RGCs) and additionally, recent evidence shows that specific antibody-derived signature peptides are significantly differentially expressed in sera of primary-open angle glaucoma patients (POAG) compared to healthy controls. Synthetically antibody-derived peptides can modulate various effector functions of the immune system and act as antimicrobial or antiviral molecules. In an ex vivo adolescent glaucoma model, this study, for the first time, demonstrates that polyclonal-derived complementarity-determining regions (CDRs) can significantly increase the survival rate …

<i>Sus scrofa domestica</i>lcsh:MedicineRetinal ganglionEpitopeArticleSus scrofa domestica03 medical and health scienceschemistry.chemical_compound0302 clinical medicineImmune systemMedicine030304 developmental biology0303 health sciencesHTRA2synthetic CDR peptidesbusiness.industrylcsh:RautoimmunityRetinalGeneral MedicineProtein ubiquitinationCell biologyglaucomachemistryneuroprotectionSignal transductionbusinessVDAC2030217 neurology & neurosurgeryEx vivoJournal of Clinical Medicine
researchProduct

Identification and expansion of human colon-cancer-initiating cells

2007

Colon carcinoma is the second most common cause of death from cancer. The isolation and characterization of tumorigenic colon cancer cells may help to devise novel diagnostic and therapeutic procedures. Although there is increasing evidence that a rare population of undifferentiated cells is responsible for tumour formation and maintenance, this has not been explored for colorectal cancer. Here, we show that tumorigenic cells in colon cancer are included in the high-density CD133+ population, which accounts for about 2.5% of the tumour cells. Subcutaneous injection of colon cancer CD133+ cells readily reproduced the original tumour in immunodeficient mice, whereas CD133- cells did not form …

AC133 Antigen; Animals; Antigens CD; Cell Differentiation; Cell Line Tumor; Cell Proliferation; Colonic Neoplasms; Glycoproteins; Humans; Mice; Mice SCID; Neoplasm Transplantation; Neoplastic Stem Cells; Peptides; Phenotype; Transplantation Heterologous; MultidisciplinaryColorectal cancerCellular differentiationPopulationTransplantation HeterologousTumor initiationMice SCIDBiologyColon carcinomasmedicine.disease_causeSCIDCell LineMiceSide populationCancer stem cellAntigens CDSettore MED/04 - PATOLOGIA GENERALECell Line TumormedicineAnimalsHumansAC133 AntigenAntigenseducationCell ProliferationGlycoproteinseducation.field_of_studyTransplantationHeterologousTumorMultidisciplinaryCancerCell Differentiationmedicine.diseaseCDPhenotypeImmunologyColonic NeoplasmsCancer researchNeoplastic Stem CellsCarcinogenesisPeptidesNeoplasm Transplantation
researchProduct